Metformin Interdos Pharma

Active Ingredient:: Metformin Hydrochloride
Origin:: EU

Metformin Interdos Pharma (Metformin Hydrochloride)

Q: What is Metformin Interdos Pharma used for?

Metformin Interdos Pharma contains Metformin Hydrochloride, which is prescribed to improve glycemic control in adults with type 2 diabetes mellitus. It helps lower elevated blood glucose levels and reduces long‑term complications associated with the disease.

Q: How does Metformin Hydrochloride work?

Metformin Hydrochloride works by activating AMP‑activated protein kinase (AMPK), which suppresses hepatic glucose production and enhances peripheral uptake of glucose into muscle and fat cells. This dual action improves overall insulin sensitivity without stimulating insulin secretion.

Q: What is the usual dose of Metformin Interdos Pharma?

The appropriate dose of Metformin Interdos Pharma is individualized by the prescribing healthcare professional based on the patient’s renal function, glycemic targets, and tolerability. Dosage adjustments are made according to clinical response and safety considerations.

Q: Is Metformin Interdos Pharma safe during pregnancy or breastfeeding?

Safety of Metformin Interdos Pharma in pregnancy or while breastfeeding has not been definitively established. Women who are pregnant, planning pregnancy, or nursing should discuss potential risks and benefits with their healthcare provider before using the medication.

Q: How do I order Metformin Interdos Pharma from GNH India?

To order Metformin Interdos Pharma, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Q: How does Metformin compare with other antidiabetic drugs?

Metformin belongs to the biguanide class and differs from sulfonylureas or insulin by not stimulating insulin release. It carries a lower risk of hypoglycemia and can aid modest weight loss, whereas sulfonylureas may cause weight gain and higher hypoglycemia rates. Insulin provides more potent glucose lowering but requires injection.

Q: What are the storage requirements for Metformin Interdos Pharma?

Metformin Interdos Pharma should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Q: How is Metformin Interdos Pharma administered?

Metformin Interdos Pharma is taken orally as a tablet. It should be swallowed whole with a full glass of water, preferably with meals to reduce gastrointestinal discomfort. The exact timing and frequency are determined by the prescribing clinician.

Q: What are the most serious risks to watch for while taking Metformin?

The most serious adverse reactions associated with Metformin include lactic acidosis—a rare but potentially fatal buildup of lactate—and severe hypoglycemia when combined with other glucose‑lowering agents. Long‑term therapy may also lead to vitamin B12 deficiency, so periodic monitoring is advisable.

Q: Who should not use Metformin Interdos Pharma?

Metformin Interdos Pharma is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and those with known hypersensitivity to metformin. Caution is also advised for individuals with significant hepatic disease or a history of lactic acidosis.

Metformin Hydrochloride, the active ingredient in Metformin Interdos Pharma, is a biguanide presented as an oral tablet for oral use. It lowers elevated blood glucose by improving insulin sensitivity and decreasing hepatic glucose production, and is indicated for the management of type 2 diabetes mellitus in adult patients.

GNH India supplies Metformin Interdos Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics, and health‑care systems, ensuring consistent quality and regulatory compliance across markets throughout globally.

Manufacturer / TM Owner

Interdos Pharma Bv.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformin Hydrochloride is used to improve glycemic control in the metabolic disorder of type 2 diabetes mellitus.

Type 2 diabetes mellitus: improves blood glucose control and reduces HbA1c levels.
Impaired glucose tolerance: delays progression to type 2 diabetes by enhancing insulin sensitivity.
Polycystic ovary syndrome: improves insulin resistance and may help regulate menstrual cycles.

How It Works

Metformin Hydrochloride primarily inhibits hepatic gluconeogenesis by activating AMP‑activated protein kinase (AMPK), which reduces glucose output. It also increases peripheral glucose uptake in muscle and adipose tissue and improves insulin receptor signaling, collectively enhancing insulin sensitivity without directly stimulating insulin secretion.

Side Effects

Metformin Hydrochloride may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite.
Diarrhea: frequent loose stools, especially during treatment initiation.
Metallic taste: transient alteration in taste perception.
Flatulence: increased intestinal gas.
Weight loss: mild reduction in body weight.

Serious or Rare Side Effects

Lactic acidosis: rare but life‑threatening accumulation of lactate.
Severe hypoglycemia: may occur when combined with other glucose‑lowering agents.
Vitamin B12 deficiency: long‑term use can reduce B12 absorption.
Hepatic dysfunction: abnormal liver enzymes or hepatitis.
Skin reactions: severe rash or Stevens‑Johnson syndrome.

Precautions & Warnings

When prescribing Metformin Hydrochloride, clinicians should observe several safety considerations.

Renal function assessment: evaluate eGFR before initiation and periodically.
Monitor blood glucose: adjust therapy based on glycemic response.
Avoid in severe renal impairment: contraindicated when eGFR <30 mL/min/1.73 m².
Caution in hepatic disease: risk of lactic acidosis may increase.
Limit alcohol intake: excessive alcohol can precipitate lactic acidosis.
Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Avoid Interactions

Metformin Hydrochloride has known drug interactions that may require dose adjustment or avoidance.

Major Interactions (Avoid)

Iodinated contrast agents: can precipitate acute renal failure and increase lactic acidosis risk.
Cimetidine: may raise metformin plasma concentrations.
Alcohol excess: enhances risk of lactic acidosis.
Diuretics (loop or thiazide): may impair renal function, elevating metformin levels.
Nitrates: concurrent use can increase risk of hypotension.

Moderate Interactions (Monitor Closely)

Beta‑blockers: may mask hypoglycemia symptoms.
ACE inhibitors or ARBs: monitor renal function and potassium.
Sulfonylureas: increased risk of hypoglycemia when combined.
Digoxin: may require monitoring of serum levels.
Thyroid hormones: may affect glucose metabolism.

Frequently Asked Questions

Metformin Interdos Pharma contains Metformin Hydrochloride, which is prescribed to improve glycemic control in adults with type 2 diabetes mellitus. It helps lower elevated blood glucose levels and reduces long‑term complications associated with the disease.

Metformin Hydrochloride works by activating AMP‑activated protein kinase (AMPK), which suppresses hepatic glucose production and enhances peripheral uptake of glucose into muscle and fat cells. This dual action improves overall insulin sensitivity without stimulating insulin secretion.

The appropriate dose of Metformin Interdos Pharma is individualized by the prescribing healthcare professional based on the patient’s renal function, glycemic targets, and tolerability. Dosage adjustments are made according to clinical response and safety considerations.

Safety of Metformin Interdos Pharma in pregnancy or while breastfeeding has not been definitively established. Women who are pregnant, planning pregnancy, or nursing should discuss potential risks and benefits with their healthcare provider before using the medication.

To order Metformin Interdos Pharma, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin belongs to the biguanide class and differs from sulfonylureas or insulin by not stimulating insulin release. It carries a lower risk of hypoglycemia and can aid modest weight loss, whereas sulfonylureas may cause weight gain and higher hypoglycemia rates. Insulin provides more potent glucose lowering but requires injection.

Metformin Interdos Pharma should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Metformin Interdos Pharma is taken orally as a tablet. It should be swallowed whole with a full glass of water, preferably with meals to reduce gastrointestinal discomfort. The exact timing and frequency are determined by the prescribing clinician.

The most serious adverse reactions associated with Metformin include lactic acidosis—a rare but potentially fatal buildup of lactate—and severe hypoglycemia when combined with other glucose‑lowering agents. Long‑term therapy may also lead to vitamin B12 deficiency, so periodic monitoring is advisable.

Metformin Interdos Pharma is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and those with known hypersensitivity to metformin. Caution is also advised for individuals with significant hepatic disease or a history of lactic acidosis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 05 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.